𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential expression of galectin 3 and galectin 1 in colorectal cancer progression

✍ Scribed by X Sanjuan; PL Fernandez; A Castells; V Castronovo; F van den Brule; FT Liu; A Cardesa; E Campo

Book ID
118519717
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
677 KB
Volume
113
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Differential expression of Galectin-1 an
Differential expression of Galectin-1 and Galectin-3 during first trimester human embryogenesis
✍ FrΓ©dΓ©ric A. van den BrΓ»le; Pedro L. Fernandez; Crina Buicu; Fu-Tong Liu; Pascale πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 2 views

Development of complex organisms requires specific temporospatial differentiation and expression of the correct phenotype through activation of a variety of genes. Galectins are mammalian lectins able to interact with various extracellular matrix glycoconjugates and have been implicated in several b

The role of galectins in colorectal canc
The role of galectins in colorectal cancer progression
✍ Hannah Barrow; Jonathan M. Rhodes; Lu-Gang Yu πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 291 KB

## Abstract Galectins constitute a family of 15 mammalian galactoside‐binding proteins that share a consensus amino acid sequence in their carbohydrate binding sites. They are multi‐functional molecules and are expressed widely in human tissues. Four galectins: galectin βˆ’1, βˆ’3, βˆ’4 and βˆ’8 are expres

Galectin-1 and galectin-3 expression in
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas
✍ Luca Cindolo; Giovanna Benvenuto; Paola Salvatore; Raffaela Pero; Gaetano Salvat πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 133 KB πŸ‘ 2 views

Galectin-1 and galectin-3 are galactoside-binding proteins involved in different steps of tumor progression and potential targets for therapy. We have investigated the expression of these galectins in 38 human bladder transitional-cell carcinomas of different histological grade and clinical stage an